Novo Holdings
Novo Holdings is a leading holding and investment company responsible for managing the assets and wealth of the Novo Nordisk Foundation, one of the world's largest enterprise foundations. As the controlling shareholder of Novo Nordisk and Novonesis, Novo Holdings manages a diverse investment portfolio with a long-term return perspective. The firm invests in life science companies at all stages of development and manages a broad portfolio of equities, bonds, real estate, infrastructure, and private equity investments. With a mission to improve people's health and the sustainability of society and the planet, Novo Holdings aims to generate attractive long-term returns on the assets of the Novo Nordisk Foundation.
Novo Holdings
Tuborg Havnevej 19, 2900 Hellerup, Denmark
Portfolio
Building a portfolio of therapeutics for the treatment of rare pediatric neurodegenerative diseases.
#Life Sciences
Develops and commercialises novel and proprietary minimal energy resource recovery technologies for high total dissolved solids (TDS) waste and process streams.
#Technology
Clinical-stage biotechnology company developing novel targeted radiopharmaceuticals using camelid single domain antibody fragments.
#Biotechnology
Cloud platform solutions provider supporting the capture of efficacy and safety endpoints, harmonising data from any clinical source system, and delivering real-time insights for optimal clinical trial performance.
#Technology
Leader in payer-provider collaboration, providing digital provider engagement, clearinghouse, and revenue cycle technology solutions.
#Healthcare Technology
Developing an improved therapy for the treatment of Idiopathic Pulmonary Fibrosis (IPF).
#Pharmaceuticals
Leading supplier of products and services to the global diagnostics and life sciences industries, with manufacturing sites spanning four continents.
#Diagnostics and Life Sciences
Key People
CEO